Medicina
Fachbereich
Jordi
Bruix Tudó
Publikationen, an denen er mitarbeitet Jordi Bruix Tudó (33)
2022
-
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Liver International, Vol. 42, Núm. 8, pp. 1891-1901
2021
-
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports, Vol. 3, Núm. 3
-
Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884] (Journal of Hepatology (2019) 70(5) (874–884), (S0168827819300157), (10.1016/j.jhep.2019.01.005))
Journal of Hepatology
-
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH
Medicina Clinica, Vol. 156, Núm. 9, pp. 463.e1-463.e30
-
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice
European Journal of Radiology, Vol. 135
-
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
Liver Transplantation, Vol. 27, Núm. 12, pp. 1767-1778
2020
-
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
Liver International, Vol. 40, Núm. 6, pp. 1467-1476
2019
-
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
American Journal of Transplantation, Vol. 19, Núm. 11, pp. 3176-3184
2016
-
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Journal of Hepatology, Vol. 65, Núm. 4, pp. 719-726
2010
-
Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma
European Journal of Gastroenterology and Hepatology, Vol. 22, Núm. 10, pp. 1239-1244
-
Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros
Medicina Clinica, Vol. 134, Núm. 13, pp. 569-576
2009
-
Diagnóstico y tratamiento del carcinoma hepatocelular
Medicina Clinica, Vol. 132, Núm. 7, pp. 272-287
-
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: Are response evaluation criteria in solid tumors reliable?
Cancer, Vol. 115, Núm. 3, pp. 616-623
2008
-
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
Hepatology, Vol. 47, Núm. 1, pp. 97-104
-
Malignant Tumours
Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition (Blackwell Publishing Ltd), pp. 1437-1463
2007
-
Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
Journal of Hepatology, Vol. 46, Núm. 3, pp. 474-481
-
Hepatoma
Medical Care of the Liver Transplant Patient: Third Edition (Blackwell Publishing Ltd), pp. 119-138
-
Liver transplantation in hepatocellular carcinoma. Validity of the Milan criteria
Gastroenterologia y Hepatologia
-
Reply: Chemoembolization with drug eluting beads in HCC>
Journal of Hepatology